Bubs Australia Ltd
Bubs Australia Limited is an Australia-based producer of infant and adult chilled and powdered, goat dairy products.
The business
Bubs Australia Limited is an Australia-based producer of infant and adult chilled and powdered, goat dairy products. It offers families around the world a comprehensive range of Australian premium infant nutrition products under the Bubs brand, including goat milk infant formula, organic grass-fed cow milk infant formula, organic baby food, cereals, toddler snacks, as well as a range of adult nutritional powders and chilled goat milk under the Caprilac brand. Bubs A2 Beta-Casein Protein, Bubs Organic Grass-fed, and Easy-Digest Goat Milk Infant Formula, along with Bubs Organic baby food range, cater for all feeding occasions and stages of a child’s development during their first 1,000 days of life. Its organic food range includes organic plant burst pouches, organic snack range and organic baby cereal. Its products are sold in supermarkets and pharmacies throughout Australia, as well as exported to around 10 markets across China, Southeast Asia, the Middle East, and United States.
Small Caps Research
No research on Bubs Australia Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise BUB based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news
Bubs Australia Boosts FY26 Outlook on Strong US Growth
Bubs Australia lifts FY26 outlook on robust US growth, guiding $120-125M revenue and $4-6M EBITDA as US revenue jumps 48% to $34.2M.
Market wrap: Australia ignores Wall Street record on faltering miners
The Australian share market once again ignored a rally on Wall Street to a fresh record high and closed down 0.3% thanks to a broad-based slump on Friday. It was yet another reminder of how the Australian bourse with its heavy concentration of miners and banks has disconnected from the Artificial Intelligence rally that is […]
Bubs Australia reports strong US sales and rebounding Chinese market
Organic infant formula manufacturer Bubs Australia (ASX: BUB) has reported continued strong performance of its product range in the US market. The company’s weekly scan revenue has exceeded US$1 million with over 24,000 tins sold, compared to US$750,000 in revenue for the previous quarter. It retained the position of the best-selling infant formula product on […]
Bubs Australia launches infant formula trial to secure the US market
Bubs Australia (ASX: BUB) has commenced nationwide enrolment for a growth monitoring study (GMS) in the US as part of its ongoing commitment to serving the North American market. The first infant was enrolled in late August and the company is actively enrolling more patients online and through 13 healthcare clinics across the country. The […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.